Shionogi to Acquire Intrabio Inc. for Rare Disease Expansion
Shionogi & Co., Ltd. announced its planned acquisition of Intrabio Inc. as part of its ongoing expansion in the rare disease sector.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Shionogi & Co., Ltd. announced its planned acquisition of Intrabio Inc. as part of its ongoing expansion in the rare disease sector.